Laroscorbine Sans Sucre

Ascorbic acid, the active ingredient in Laroscorbine Sans Sucre, is a vitamin presented as an oral tablet for oral use. It prevents vitamin C deficiency and supports normal immune function in the general population.

GNH USA supplies Laroscorbine Sans Sucre as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Laroscorbine Sans Sucre (ascorbic acid) is used to address conditions related to vitamin C deficiency and oxidative stress. - Prevention of vitamin C deficiency (scurvy): reduces the risk of scurvy in individuals with inadequate dietary intake. - Support of normal immune function: contributes to the activity of immune cells and helps maintain resistance to infections. - Antioxidant supplementation: neutralises free radicals and supports overall cellular health.

Adverse reactions to oral ascorbic acid are generally mild but can occur.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Diarrhoea: loose stools, especially at higher doses. - Abdominal cramps: discomfort or cramping in the abdomen. - Headache: transient mild headache. - Metallic taste: temporary alteration of taste perception. - Flushing: mild facial warmth.

Serious or Rare Side Effects: - Kidney stones: oxalate stone formation in predisposed individuals. - Allergic reactions: rash, itching, or angioedema. - Hemolysis in G6PD deficiency: rapid breakdown of red blood cells. - Severe abdominal pain: persistent, intense pain requiring medical evaluation. - Anaphylaxis: rare, life‑threatening systemic allergic response.

When using Laroscorbine Sans Sucre, consider the following safety measures. - Assess dietary intake: ensure supplementation is needed based on nutritional assessment. - Monitor renal risk: patients with a history of kidney stones should use caution. - Use in renal impairment: adjust use in severe kidney disease. - Avoid excess dosing: high chronic doses may increase oxalate burden. - Consider G6PD deficiency: screen before high‑dose therapy. - Store at ambient temperature: keep in the original pack, protect from moisture.

Vitamin C can influence the activity of several other medicines.

Major Interactions (Avoid): - Chemotherapy agents (e.g., bortezomib, cyclophosphamide): high‑dose vitamin C may reduce anticancer efficacy. - Anticoagulants (e.g., warfarin): large amounts can affect INR and bleeding risk.

Moderate Interactions (Monitor Closely): - Iron supplements: increased iron absorption may exacerbate iron overload conditions. - Aluminum‑containing antacids: may reduce vitamin C absorption. - Statins: high doses of vitamin C could theoretically increase the risk of myopathy, requiring monitoring.